Ac-5SGlcNAc treatment also blocks serum-stimulated cyclin D1 synthesis during the G0/G1 transition of breast cancer cells, suggesting that the role of OGT inhibitors in regulating the cell cycle further affects cell proliferation (123). Here, OGT is linked to breast cancer.